Package 60687-294-21

{"route": ["ORAL"], "spl_id": "3f173cc6-1846-9797-e063-6394a90ad8eb", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182141", "N0000182140", "N0000185504"], "unii": ["JFU09I87TR"], "rxcui": ["349434", "349435"], "spl_set_id": ["8379ac92-53cd-46db-8642-017f11830a86"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "manufacturer_name": ["American Health Packaging"]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-294-21)  / 1 TABLET, FILM COATED in 1 BLISTER PACK (60687-294-11)", "package_ndc": "60687-294-21", "marketing_end_date": "20260630", "marketing_start_date": "20180307"}], "brand_name": "Voriconazole", "product_id": "60687-294_3f173cc6-1846-9797-e063-6394a90ad8eb", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "60687-294", "generic_name": "Voriconazole", "labeler_name": "American Health Packaging", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Voriconazole", "active_ingredients": [{"name": "VORICONAZOLE", "strength": "50 mg/1"}], "application_number": "ANDA203503", "marketing_category": "ANDA", "marketing_end_date": "20260630", "marketing_start_date": "20180307"}